Evidence map›Paper›PMID 26085481›Full record

ArticleFood & nutrition research2015

A multi-ingredient, pre-workout supplement is apparently safe in healthy males and females.

Jordan M Joy, Ryan P Lowery, Paul H Falcone, Roxanne M Vogel, Matt M Mosman, Chih-Yin Tai, Laura R Carson, Dylan Kimber, David Choate, Michael P Kim and 2 more

Abstract read
In one paragraph

Article in Food & nutrition research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. International society of sports nutrition position stand: caffeine and exercise performance.Journal of the International Society of Sports Nutrition · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jordan M JoyMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Ryan P LoweryHealth Science and Human Performance Department, University of Tampa, Tampa, FL, USA.
Paul H FalconeMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Roxanne M VogelMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Matt M MosmanMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Chih-Yin TaiMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Laura R CarsonMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Dylan KimberMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
David ChoateMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Michael P KimMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.
Jacob M WilsonHealth Science and Human Performance Department, University of Tampa, Tampa, FL, USA.
Jordan R MoonMusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPre-workout supplements (PWS) have become increasingly popular with recreational and competitive athletes. While many ingredients used in PWS have had their safety assessed, the interactions when combined are less understood.

objectiveThe purpose of this study was to examine the safety of 1 and 2 servings of a PWS.

designForty-four males and females (24.4±4.6 years; 174.7±9.3 cm; 78.9±18.6 kg) from two laboratories participated in this study. Subjects were randomly assigned to consume either one serving (G1; n=14) or two servings (G2; n=18) of PWS or serve as an unsupplemented control (CRL; n=12). Blood draws for safety panels were conducted by a trained phlebotomist before and after the supplementation period.

resultsPooled data from both laboratories revealed significant group×time interactions (p<0.05) for mean corpuscular hemoglobin (MCH; CRL: 30.9±0.8-31.0±0.9 pg; G1: 30.7±1.1-30.2±0.7 pg; G2: 30.9±1.2-30.9±1.1 pg), MCH concentration (CRL: 34.0±0.9-34.4±0.7 g/dL; G1: 34.1±0.9-33.8±0.6 g/dL; G2: 34.0±1.0-33.8±0.8 g/dL), platelets (CRL: 261.9±45.7-255.2±41.2×10(3)/µL; G1: 223.8±47.7-238.7±49.6×10(3)/µL; G2: 239.1±28.3-230.8±34.5×10(3)/µL), serum glucose (CRL: 84.1±5.2-83.3±5.8 mg/dL; G1: 86.5±7.9-89.7±5.6 mg/dL; G2: 87.4±7.2-89.9±6.6 mg/dL), sodium (CRL: 137.0±2.7-136.4±2.4 mmol/L; 139.6±1.4-140.0±2.2 mmol/L; G2: 139.0±2.2-138.7±1.7 mmol/L), albumin (CRL: 4.4±0.15-4.4±0.22 g/dL; G1: 4.5±0.19-4.5±0.13 g/dL; G2: 4.6±0.28-4.3±0.13 g/dL), and albumin:globulin (CRL: 1.8±0.30-1.8±0.28; G1: 1.9±0.30-2.0±0.31; G2: 1.8±0.34-1.8±0.34). Each of these variables remained within the clinical reference ranges.

conclusionsThe PWS appears to be safe for heart, liver, and kidney function in both one-serving and two-serving doses when consumed daily for 28 days. Despite the changes observed for select variables, no variable reached clinical significance.

Indexed as

caffeinehematologynitratessports supplementtoxicity

Identifiers

PMID26085481
PMCPMC4471216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.